Rosuvastatin alone or with extended-release niacin: a new therapeutic option for patients with combined hyperlipidemia. [electronic resource]
Producer: 20041209Description: 176-81 p. digitalISSN:- 1520-037X
- Adult
- Apolipoproteins -- blood
- Cholesterol -- blood
- Cholesterol, HDL -- blood
- Cholesterol, LDL -- blood
- Delayed-Action Preparations
- Drug Therapy, Combination
- Female
- Fluorobenzenes -- administration & dosage
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- administration & dosage
- Hyperlipidemias -- blood
- Male
- Middle Aged
- Niacin -- administration & dosage
- Pyrimidines -- administration & dosage
- Rosuvastatin Calcium
- Sulfonamides -- administration & dosage
- Treatment Outcome
- Triglycerides -- blood
- United States
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.